✨ Free AI Report
Takeda Pharmaceutical Company Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Takeda Pharmaceutical Company Limited
Company Research

Takeda Pharmaceutical Company Limited: Business Overview, Financials & Competitive Analysis

Takeda Pharmaceutical Company Limited scores 7/10 on the AskCyborg Cyborg Score (Strong). Established global pharma leader with strong revenue growth, robust rare disease and oncology pipelines, and positive clinical data supporting near-term catalysts. In fiscal year 2025, Takeda Pharmaceutical's revenue was 4.58 trillion, an increase of 7.45% compared to the previous year's 4.26 trillion. The company has multiple pipeline advances.

What is Takeda Pharmaceutical Company Limited's industry? Takeda Pharmaceutical Company Limited (takeda.com) operates in Pharmaceutical Manufacturing & Biotechnology. AskCyborg classifies Takeda Pharmaceutical Company Limited under Pharmaceutical Manufacturing & Biotechnology in its company registry.

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gast...

7/ 10Strong

Cyborg Score thesis

Established global pharma leader with strong revenue growth, robust rare disease and oncology pipelines, and positive clinical...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing & Biotechnology
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Takeda Pharmaceutical Company Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Takeda Pharmaceutical Company Limited

AskCyborg analysts argue the bull and bear cases for Takeda Pharmaceutical Company Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Takeda Pharmaceutical Company Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Takeda Pharmaceutical Company Limited Overview

Pro stress-test →

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases).

Strategic Profile

Pro stress-test →

Takeda maintains its position as a global biopharmaceutical leader through continuous innovation in oncology, gastroenterology, and rare disease therapies. Takeda makes strategic investments in internal and external opportunities to enhance its pipeline, new product launches, and plasma-derived therapies.

Competitive Landscape

Pro stress-test →

Takeda maintains its position as a global biopharmaceutical leader through continuous innovation in oncology, gastroenterology, and rare disease therapies. The company competes with major pharmaceutical players across multiple therapeutic areas including rare diseases, gastrointestinal treatments, and plasma-derived therapies. Key competitive positioning is driven by proprietary drug development and strategic partnerships.

Industry Context

Takeda Pharmaceutical Company Limited operates in Pharmaceutical Manufacturing & Biotechnology.

Key facts

Founded: 1781 · Headquarters: Osaka, Japan · Employees: N/A · Revenue: 4.58T JPY (FY2025) · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Takeda Pharmaceutical Company Limited.

  • Takeda presented Phase 3 clinical trial results for oveporexton, their first-in-class oral orexin receptor agonist for narcolepsy type 1, with studies meeting all primary and secondary endpoints, with 85% of participants achieving normal sleepiness scores and over 80% reduction in cataplexy rates.
  • FDA accepted New Drug Application and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 with a PDUFA goal date in the third quarter of this calendar year.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026FDA grants Priority Review for oveporexton narcolepsy drug
  • February 2026Takeda advances oral Crohn's disease drug TAK-279 with active mid-stage trial
  • +2 moreTrack every material event for Takeda Pharmaceutical Company Limited as it happens. Explore monitoring →
Get alerted when Takeda Pharmaceutical Company Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

RegeneronRare disease and immunology focus→VertexRare genetic diseases→Novo NordiskGastrointestinal and rare disease therapies→PfizerDiversified pharma oncology and specialty care→

Compare Takeda Pharmaceutical Company Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Takeda Pharmaceutical Company Limited operates in Pharmaceutical Manufacturing & Biotechnology. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing & Biotechnology research →
NEW · MCP server

Ask your AI assistant about Takeda Pharmaceutical Company Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Takeda Pharmaceutical Company Limited and its top competitor on Cyborg Score”
“What did Takeda Pharmaceutical Company Limited do this quarter?”
“Is Takeda Pharmaceutical Company Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Takeda Pharmaceutical Company Limited do?+
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gast...
What is Takeda Pharmaceutical Company Limited's Cyborg Score?+
Takeda Pharmaceutical Company Limited has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Takeda Pharmaceutical Company Limited's main competitors?+
Named competitors include Regeneron, Vertex, Novo Nordisk, Pfizer. The full competitive landscape is in the AskCyborg report.
How can I get the full Takeda Pharmaceutical Company Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Takeda Pharmaceutical Company Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Takeda Pharmaceutical Company Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceutical Manufacturing & Biotechnology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Takeda Pharmaceutical Company Limited7Vertex, Inc.7Pfizer Inc.